Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T20:35:21.825Z Has data issue: false hasContentIssue false
  • English
  • Français

Supporting cancer patients quit smoking: the initial evaluation of our tobacco cessation intervention program

Published online by Cambridge University Press:  01 July 2019

Ernest Osei Open the ORCID record for Ernest Osei [Opens in a new window] ,
Rahil Kassim ,
Kelly A. Cronin  and
Barbara-Anne Maier
Ernest Osei*
Affiliation:
Department of Medical Physics, Grand River Regional Cancer Centre, Kitchener, ON, Canada Department of Physics and Astronomy, University of Waterloo, Waterloo, ON, Canada Department of Systems Design Engineering, University of Waterloo, Waterloo, ON, Canada Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ONCanada
Rahil Kassim
Affiliation:
Department of Medical Physics, Grand River Regional Cancer Centre, Kitchener, ON, Canada School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada
Kelly A. Cronin
Affiliation:
Department of Oncology Prevention, Grand River Regional Cancer Centre, Kitchener, ON, Canada
Barbara-Anne Maier
Affiliation:
Department of Oncology Prevention, Grand River Regional Cancer Centre, Kitchener, ON, Canada
*
Author for correspondence: Ernest Osei, Department of Medical Physics, Grand River Regional Cancer Centre, Kitchener, ON, Canada. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Tobacco is a known addictive consumer product and its use has been reported to be associated with several health problems as well as the leading cause of premature, preventable mortality worldwide. For patients undergoing cancer treatment, tobacco smoking can potentially compromise treatment effectiveness; however, there is sufficient evidence suggesting numerous health benefits of smoking cessation interventions for cancer patients.

Methods:

The Grand River Regional Cancer Centre (GRRCC) smoking cessation program began in October 2013 to provide evidence-based intensive tobacco intervention to patients. All new patients are screened for tobacco use and those identified as active smokers are advised of the benefits of cessation and offered referral to the program where a cessation nurse offers counseling. Patients’ disease site, initial cessation goal, quit date, number of quit attempts and mode of contact are collected by the cessation nurse. This study reports on the initial evaluation of the smoking cessation program activities at GRRCC.

Results:

There are 1,210 patients who were screened, accepted a referral and counseled in the program. The referral pattern shows a modest increase every year and most of the patients (58%) indicated readiness to quit smoking. Overall, 29 and 26% of patients either quit or cut-back smoking, respectively. Among 348 patients who quit smoking, 300 (86%) were able to quit at the first attempt. The data indicated that 309 (44%) out of the 698 patients who indicated their initial intent to quit smoking were able to quit, whereas about 242 (35%) were able to cutback. A total of 15 patients out of 32 who indicated initial readiness to ‘cutback’ smoking were able to reduce tobacco use and three patients actually ended up quitting, although their initial goal was ‘ready-to-cut-back’.

Conclusions:

GRRCC smoking cessation program started in October 2013 to provide evidence-based intensive smoking cessation interventions for patients with cancer. Most patients referred to the program indicated a readiness to quit smoking affirming that if patients become aware of the various risks associated with continual smoking or if they are informed of the benefits associated with cessation with regard to their treatment, they will be more likely to decide to quit. Therefore, it is essential that patients, their partners and families are counseled on the health and treatment benefits of smoking cessation and sustainable programs should be available to support them to quit smoking. It is imperative then, that oncology programs should consistently identify and document the smoking status of cancer patients and support those who use tobacco at the time of diagnosis to quit. Evidence-based smoking cessation intervention should be sustainably integrated into the cancer care continuum in all oncology programs from prevention of cancer through diagnosis, treatment, survivorship and palliative care.

Keywords

cancer patients interventioncancer treatmentchemotherapyradiation therapysmoking cessation
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 19 , Issue 2 , June 2020 , pp. 163 - 172
Copyright
© Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Warren, G W, Alberg, A J, Kraft, A Set al. The 2014 Surgeon General’s report: ‘The health consequences of smoking—50 years of progress’: a paradigm shift in cancer care. Cancer 2014; 120 (13): 1914–1916. doi: 10.1002/cncr.28695">10.1002/cncr.28695CrossRefGoogle Scholar
Nash, S H, Liao, L M, Harris, T Bet al. Cigarette smoking and mortality in adults aged 70 years and older: results from the NIH-AARP cohort. Am J Prev Med 2017; 52 (3): 276–283.CrossRefGoogle ScholarPubMed
Jha, P, Ramasundarahettige, C, Landsman, Vet al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368 (4): 341–350.CrossRefGoogle ScholarPubMed
U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.Google Scholar
Statistic Canada. Canadian tobacco, alcohol and drugs survey, 2017. Released: 2018-10-30 https://www150.statcan.gc.ca/n1/daily-quotidien/181030/dq181030b-eng.pdf. Accessed on March 2019.Google Scholar
Shiels, M S, Gibson, T, Sampson, Jet al. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol 2014; 32 (35): 3989–3995.CrossRefGoogle ScholarPubMed
Vineis, P, Alavanja, M, Buffler, Pet al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96 (2): 99–106.CrossRefGoogle ScholarPubMed
Kassim, R, Osei, E, Cronin, K A.A review of the effects of tobacco smoking on cancer treatment: smoking cessation intervention should be integrated into the cancer care continuum. J Radiother Pract 2019: 1–9. doi: 10.1017/S1460396919000360Google Scholar
Toll, B A, Brandon, T H, Gritz, E Ret al. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res 2013; 19 (8): 1941–1948.CrossRefGoogle Scholar
Gritz, E R, Fingeret, M C, Vidrine, D Jet al. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006; 106 (1): 17–27.CrossRefGoogle ScholarPubMed
Fagerstrom, K.The epidemiology of smoking: health consequences and benefits of cessation. Drugs 2002; 62 (S2): 1–9.CrossRefGoogle ScholarPubMed
Gritz, E R.Smoking and smoking cessation in cancer patients. Br J Addict 1991; 86 (5): 549–554.CrossRefGoogle ScholarPubMed
McBride, C M, Ostroff, J S.Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003; 10 (4): 325–333.CrossRefGoogle ScholarPubMed
Warren, G W, Kasza, K A, Reid, M Eet al. Smoking at diagnosis and survival in cancer patients. Int J Cancer 2013; 132 (2): 401–410.CrossRefGoogle ScholarPubMed
A Clinical Practice Guideline for Treating Tobacco Use and Dependence: A US Public Health Service Report. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. J Am Med Assoc 2000; 283 (24): 3244–3254.CrossRefGoogle Scholar
Hughes, J R, Keely, J, Naud, S.Shape of the relapse curve and long–term abstinence among untreated smokers. Addiction 2004; 99 (1): 29–38.CrossRefGoogle ScholarPubMed
Stead, L F, Buitrago, D, Preciado, Net al. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013; 5. Art. No.: CD000165. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000165.pub4Google Scholar
Ottawa Model for Smoking Cessation in Ontario Primary Care Teams: Annual Report. 2013–14. https://ottawamodel.ottawaheart.ca/sites/ottawamodel.ottawaheart.ca/files/omsc_whatsnew/omsc_in_pc_annual_report_2013-14_final.pdf. Accessed on March 2019.Google Scholar
Can-adaptt: Canadian smoking cessation guideline. 2011. https://www.nicotinedependenceclinic.com/English/CANADAPTT/Documents/Guideline/Counselling%20and%20Psychosocial%20Approaches.pdf. Accessed on March 2019.Google Scholar
Boudreaux, E D, Sullivan, A, Abar, Bet al. Motivation rulers for smoking cessation: a prospective observational examination of construct and predictive validity. Addict Sci Clin Pract 2012; 7 (1): 1–9. doi: 10.1186/1940-0640-7-8CrossRefGoogle ScholarPubMed
Prochaska, J O, Velicer, W F.The transtheoretical model of health behavior change. Am J Health Promotion 1997; 12 (1): 38–48.CrossRefGoogle ScholarPubMed
Carrozzi, L, Pistelli, F, Viegi, G.Pharmacotherapy for smoking cessation. Ther Adv Respir Dis 2008; 2 (5): 301–317.CrossRefGoogle ScholarPubMed
Roberts, N J, Kerr, S M, Smith, S M S. Behavioral interventions associated with smoking cessation in the treatment of tobacco use. Health Serv Insights 2013; 6: 79–85.Google ScholarPubMed
Bondy, S J, Diemert, L M, Victor, J Cet al. Assessing the reach of nicotine replacement therapy as a preventive public health measure. Chronic Dis Inj Canada 2012; 33 (1): 19–28.Google ScholarPubMed
Papadakis, S, Tulloch, H E, Gharib, Met al. Profile of tobacco users identified in primary care practice and predictors of readiness to quit: a cross-sectional survey. CMAJ Open 2016; 4 (1): E41–E47. doi: 10.9778/cmajo.20150055CrossRefGoogle ScholarPubMed
Little, M A, Klesges, R C, Bursac, Zet al. Why don’t cancer survivors quit smoking? An evaluation of readiness for smoking cessation in cancer survivors. J Cancer Prev 2018; 23 (1): 44–50. doi: 10.15430/JCP.2018.23.1.44CrossRefGoogle ScholarPubMed
Babb, S, Malarcher, A, Schauer, Get al. Quitting smoking among adults—United States, 2000–2015. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2017; 65: 1457–1464. doi: https://dx.doi.org/10.15585/mmwr.mm6552a1external iconCrossRefGoogle Scholar
Burke, L, Miller, L-A, Saad, A.Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract 2009; 5 (1): 6–9.CrossRefGoogle ScholarPubMed
Blanchard, C, Denniston, M, Baker, Fet al. Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav 2003; 27 (3): 246–256 (11) doi: 10.5993/AJHB.27.3.6CrossRefGoogle ScholarPubMed
Stead, L F, Perera, R, Bullen, Cet al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 11. Art. No.: CD000146. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000146.pub4Google Scholar
Hartmann-Boyce, J, Chepkin, S C, Ye, Wet al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Syst Rev 2018; 5. Art. No.: CD000146. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD000146.pub5Google Scholar
U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.Google Scholar
Hays, J T, Ebbert, J O.Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. Mol Diag Ther 2003; 17 (2): 71–83.Google ScholarPubMed
Coe, J W, Brooks, P R, Vetelino, M Get al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 2005; 48 (10): 3474–3477.CrossRefGoogle ScholarPubMed
Civljak, M, Stead, L F, Hartmann-Boyce, Jet al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev 2013; 7. Art. No.: CD007078. Published by John Wiley & Sons, Ltd.doi: 10.1002/14651858.CD007078.pub4Google Scholar
Hartmann-Boyce, J, Lancaster, T, Stead, L F. Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev. 2014; (6). Art. No.: CD001118. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD001118.pub3CrossRefGoogle Scholar
Lancaster, T, Stead, L F. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2017; (3). Art. No.: CD001292. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD001292.pub3CrossRefGoogle Scholar
Stead, L F, Hartmann-Boyce, J, Perera, Ret al. Telephone counselling for smoking cessation. Cochrane database of systematic reviews 2013 Issue 8. Art. No.: CD002850. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD002850.pub3.Google Scholar
Hiscock, R, Murray, S, Brose, L Set al. Behavioural therapy for smoking cessation: the effectiveness of different interventions types for disadvantaged and affluent smokers. Addict Behav 2013; 38 (11): 2787–2796. doi: 10.1016/j.addbeh.2013.07.010. Epub 2013 Jul 21.CrossRefGoogle Scholar
Stead, L F, Koilpillai, P, Fanshawe, T Ret al. Combined pharmacotherapy and behavioural interventions for smoking cessation.Cochrane Database of Syst Rev 2016; 3.Art. No.: CD008286. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD008286.pub3.Google Scholar
Patnode, C D, Henderson, J T, Thompson, J Het al. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force. Ann Intern Med 2015; 163 (8): 608–621.CrossRefGoogle ScholarPubMed
Molyneux, A, Lewis, S, Leivers, Uet al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003; 58 (6): 484–488.CrossRefGoogle ScholarPubMed
Macleod, Z R, Arnaldi, V C, Adams, I Met al. Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial. Med J Aust 2003; 179 (7): 349–352.CrossRefGoogle ScholarPubMed
Stead, L F, Koilpillai, P, Lancaster, T.Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.Cochrane Database Syst Rev 2015; 10. Art. No.: CD009670. Published by John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD009670.pub3Google Scholar
Janz, T. Statistics Canada, Health at a Glance, Current smoking trends. Statistics Canada Catalogue no. 82-624-X. https://www150.statcan.gc.ca/n1/pub/82-624-x/2012001/article/11676-eng.htm#n4. Accessed on March 2019.Google Scholar
Richter, K P, Ellerbeck, E F.It’s time to change the default for tobacco treatment. Addiction 2015; 110 (3): 381–386.CrossRefGoogle ScholarPubMed
Davidson, S M, Boldt, R G, Louie, A V.How can we better help cancer patients quit smoking? The London Regional Cancer Program experience with smoking cessation. Curr Oncol 2018; 25 (3): 226–230. doi: 10.3747/co.25.3921CrossRefGoogle ScholarPubMed